1-deoxynojirimycin has been researched along with EHS Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beuth, J; Ko, HL; Ohshima, Y; Pulverer, G; Roszkowski, K; Uhlenbruck, G; Yassin, A | 1 |
1 other study(ies) available for 1-deoxynojirimycin and EHS Tumor
Article | Year |
---|---|
Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice.
Topics: 1-Deoxynojirimycin; Alkaloids; Animals; Carbohydrates; Cyclohexenes; Glucosamine; Glycoproteins; Inositol; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Sarcoma, Experimental; Swainsonine; Tunicamycin | 1988 |